XNCR
Price:
$24.29
Market Cap:
$1.70B
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome; and Monjuvi for the treatment of patients with relapsed or refractory diffuse large B-cell lymphoma. It develops Plamotamab, a tumor-targeted antibody, which is in Phase I clinical trial to treat non-Hodgkin lymphoma; Vudalimab, a bispecific antibody, which is in Phase II clinical trial to treat m...[Read more]
Industry
Biotechnology
IPO Date
2013-12-03
Stock Exchange
NASDAQ
Ticker
XNCR
According to Xencor, Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.
The mean historical Dividend Yield of Xencor, Inc. over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), XNCR's Dividend Yield was at its highest in in the December 2014 quarter at 0%. The Dividend Yield was at its lowest in in the December 2014 quarter at 0%.
Average
0%
Median
0%
Minimum
0%
Maximum
0%
Discovering the peaks and valleys of Xencor, Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual Dividend Yield = 0%
Minimum Annual Increase = 0%
Minimum Annual Dividend Yield = 0%
Year | Dividend Yield | Change |
---|---|---|
2023 | 0% | 0% |
2022 | 0% | 0% |
2021 | 0% | 0% |
2020 | 0% | 0% |
2019 | 0% | 0% |
2018 | 0% | 0% |
2017 | 0% | 0% |
2016 | 0% | 0% |
2015 | 0% | 0% |
2014 | 0% | 0% |
The current Dividend Yield of Xencor, Inc. (XNCR) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
0%
5-year avg
0%
10-year avg
0%
Xencor, Inc.’s Dividend Yield is less than Edgewise Therapeutics, Inc. (0%), less than Keros Therapeutics, Inc. (0%), less than Monte Rosa Therapeutics, Inc. (0%), less than Mineralys Therapeutics, Inc. (0%), less than Erasca, Inc. (0%), less than Kura Oncology, Inc. (0%), less than Protagonist Therapeutics, Inc. (0%), less than Merus N.V. (0%), less than Replimune Group, Inc. (0%), less than Cerevel Therapeutics Holdings, Inc. (0%), less than IDEAYA Biosciences, Inc. (0%), less than AnaptysBio, Inc. (0%), less than MeiraGTx Holdings plc (0%), less than Homology Medicines, Inc. (0%), less than Nuvalent, Inc. (0%), less than DICE Therapeutics, Inc. (0%), less than Arcellx, Inc. (0%), less than Vaxcyte, Inc. (0%), less than Viridian Therapeutics, Inc. (0%), less than Larimar Therapeutics, Inc. (0%), less than Syndax Pharmaceuticals, Inc. (0%), less than Sutro Biopharma, Inc. (0%),
Company | Dividend Yield | Market cap |
---|---|---|
0% | $2.80B | |
0% | $676.88M | |
0% | $433.13M | |
0% | $637.04M | |
0% | $726.61M | |
0% | $688.99M | |
0% | $2.34B | |
0% | $2.90B | |
0% | $941.76M | |
0% | $8.19B | |
0% | $2.19B | |
0% | $422.65M | |
0% | $482.21M | |
0% | $3.02M | |
0% | $5.87B | |
0% | $2.27B | |
0% | $4.20B | |
0% | $10.71B | |
0% | $1.53B | |
0% | $241.19M | |
0% | $1.12B | |
0% | $159.15M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Xencor, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Xencor, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Dividend Yield?
How can you use the Dividend Yield?
What is Xencor, Inc.'s Dividend Yield?
How is the Dividend Yield calculated for Xencor, Inc. (XNCR)?
What is the highest Dividend Yield for Xencor, Inc. (XNCR)?
What is the 3-year average Dividend Yield for Xencor, Inc. (XNCR)?
What is the 5-year average Dividend Yield for Xencor, Inc. (XNCR)?
How does the current Dividend Yield for Xencor, Inc. (XNCR) compare to its historical average?